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ABSTRACT The extreme and, apparently, selective vulnerability of chondromuco-
protein in cartilage matrix to the action of proteolytic enzymes in vivo provides
a useful model for studying factors involved in the transport, inhibition, and
activation of a protease, papain, in the blood and tissues. The lysis of cartilage
matrix which occurs in hypervitaminosis A is the result of release, probably from
chondrocytes, of cathepsins normally contained within lysosomes. Cortisone
possesses two properties which are not only of importance for this experimental
model but also may have more general bearing on the physiological functions of
this hormone with respect to connective tissue. One property is to prevent the
resynthesis or deposition of chondroitin sulfate in cartilage matrix, after deple-
tion of the latter. The other, which may be relevant to the "anti-inflammatory"
actions of cortisone, is to increase the stability of lysosomes and prevent release
of the acid hydrolytic enzymes contained in these organelles.
This paper is concerned with several techniques which can be used to bring about
rapid depletion of chondroitin sulfate from cartilage matrix in vivo. These techniques
have provided opportunities to manipulate and examine some of the physiological
mechanisms governing the regulation of this constituent of connective tissue.
In 1956, it was reported that an intravenous injection of crude papain in rabbits
caused, within a few hours, loss of the normal rigidity of cartilage to such an extent
that the ears of the animals collapsed (1). Cartilaginous tissues in all parts of the
body were found to have lost the normal degree of basophilia and metachromasia,
and, in the ear cartilage, much of the actual substance of the matrix disappeared,
leaving a shrunken cartilage plate with normal appearing chondrocytes packed side
by side. Within 2 or 3 days, the matrix was restored, and the ears were again upright.
Apart from the change in cartilage matrix, no other lesions were encountered in
these animals (although Keilner (2), using larger doses, had previously described
necrotizing changes involving the myocardium following intravenous papain). The
only evidence of inconvenience to the animals was respiratory difficulty in some,
attributable to partial collapse of the softened trachea and bronchial tubes. No his-
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tological evidence of damage or loss of metachromasia in connective tissue other
than cartilage matrix was found.
The disappearance of metachromatic matrix became evident in the cartilage plates
of the ear and trachea witiin 3 or 4 hours after papain, but the epiphyseal plates,
which seemed much more vulnerable to the effect, were found by Westerbom (3)
to show depletion as early as 10 minutes after injection.
Biochemical evidence for the release of chondroitin sulfate from cartilage into the
circulating blood was obtained by Bryant et al. (4), Tsaltas (5), and Potter et al.
(6), employing direct assays for mucopolysaccharide in the blood and urine, or
measuring the release of S35 from previously labeled cartilage. Radioautographs of
ear cartilage showed depletion of S35 within 4 hours after papain.
The active principle in papain was found to be the crystallizable papain proteinase
onrgally isolated by Kimmel and Smith (7). Initial experiments with this material
failed to produce the phenomenon, but it was then showed by McCluskey and
Thomas (8) to be highly active when injected in its oxidized, inactive state. When
activated by cysteine, intravenous injection of the enzyme caused no gross or micro-
scopic change in cartilage matrix, but when inactivated by dialysis, or by the addition
of antithiols such as parachloromercuribenzoate, iodoacetate, or iodoacetamide, the
material was rapidly effective in a dose of 2 mg per kilo.
This paradoxical behavior of the enzyme in vivo might suggest that its biological
properties with respect to cartilage in the living animal are the precise opposite of its
known proteolytic action in vitro. However, it was then shown that the ear cartilage
plates removed from animals injected with papain by vein 15 utes earlier dis-
played the same wilting and depletion of chondroitin sulfate, and at about the same
rate as in vivo, when held at 37°C (6, 8). This provided a useful method for ap-
proaching the problem more closely. Cartilage plates from animals injected with
oxidized papain underwent wilting in vitro, but not those from aimals injected with
reduced papain, indicating that the enzyme had not reached the cartilage in the
latter cases. Moreover, when the cartilage containing papain was placed in buffer
containing antithiols, wilting was prevented, while in cysteine the process was much
accelerated, indicating that the conditions for its activation are the same in vivo as
in vitro, once it had succeeded in entering the cartilage.
The experiments with papain inactivated by iodoacetamide posed a special prob-
lem, since it is generally recognized that the acetamide inactivation is not reversible.
It was at first thought that cartlage tissue must have its own technique for accom-
plishing. this feat, but Potter et al. (6) showed that the reactivation was really only
apparent, and was attributable to a portion of the enzyme present in the disulfide form
before the addition of iodoacetamide, and therefore not susceptible to alkylation.
When pains were taken to increase the proportion of enzyme in reduced form, by
repeated exposure to cysteine, iodoacetamide lost its capacity to restore the activity
of papain in vivO.
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Apart from these observations with iodoacetamide, it is worth emphasizing that
the crystalline papain inactivated by other means, e.g. parachloromercuribenzoate,
and rendered completely inert in vitro, was fully effective when injected by vein.
The findings suggested that not only is activated papain prevented from reaching
cartilage, but also there must exist a reducing system of some sort in cartilage to
restore its activity once it has gained access to this tissue.
The mechanism by which reduced, activated papain is prevented from getting into
cartilage is of some interest. The likeliest explanation is that papain in this form be-
comes rapidly bound to a protein or proteins in the blood, perhaps as substrate, and
thus fails to leave the circulation. It was shown that papain becomes bound to a pro-
tein migrating between c2-globulin and /3-globulin soon after injection (6). Further-
more, utilizing the in vitro method with whole cartilage plates, it was found that
oxidized papain mixed with fresh serum caused lysis of the matrix when added to
normal plates, while reduced, fully activated papain was prevented by some factor in
serum from affecting the plate.
Thus, there is available an experimental model in which a potent protease can
circulate in the blood in its activated form and cause no tissue damage, while the in-
activated (and therefore enzymatically undetectable) form of the same enzyme can
produce, selectively, widespread disintegration of a particular tissue. The implica-
tions of this are of considerable interest in speculating about ways in which other
potentially harmful enzymes may play a role in tissue damage.
A similar state of affairs was found to hold for two other-SH activatable plant
proteases, bromelin and ficin. When injected by vein in reduced state, they displayed
severe systemic toxicity, sometimes causing acute shock and death, but had no effect
on cartilage. When oxidized before injection, on the other hand, they were non-toxic,
but produced the same lytic action on cartilage matrix as papain (8).
It is surprising that the removal of so much of the bulk of cartilage matrix, and
the sharp decrease in the normal rigidity of this tissue, produce so little evidence of
disablement or secondary damage at weight-bearing surfaces. Westerborn (3) noted
some evidence of degenerative changes in chondrocytes of the epiphyses following
papain, and in some animals transverse cracks appeared at the junction between
epiphysis and metaphysis, but these changes were rapidly reversible. Even in rabbits
maintained on repeated injections of papain for many weeks, in which cessation of
skeletal growth and dwarfism occurred (1, 8), normal growth was restored soon
after discontinuing papain. Whatever the physiological functions of- chondroitin
sulfate in cartilage may be, they are not such as to entail obvious degrees of dysfunc-
tion when this component is removed.
The Effects of Cortisone on Replacement of Matrix. The inhibiting action
of cortisone on the synthesis of chondroitin sulfate in connective tissue has been
studied by several investigators, mainly by measurement of effects on the incorpora-
tion of S35. Layton (9) found that cortisone reduced the fixation of S35 in the skin of
LEWIS THOMAS Cartilage Matrix in Vivo 209
rats; this was confirmed by Bostr6m and Odeblad, who found the same effect in
costal cartilage (10). The findings were interpreted to mean interference by cortisone
with the exchange of the ester sulfate group of chondroitin sulfate. Schiller and
Dorfman (11), however, have presented evidence indicating that inhibition of sul-
fate incorporation is based on impaired synthesis of the entire mucopolysaccharide
molecule.
The papain effect proved to be a useful and convenient method for studying this
action of cortisone in the intact animal. It was found that the daily administration of
cortisone following a single administration of papain completely prevented the re-
constitution of cartilage matrix, and maintained the tissue in its depleted state for as
long as 4 weeks (1, 12). The inhibition was demonstrated to be due to a direct
action of cortisone on cartilage; intraarticular injections of small doses of predniso-
lone prevented recovery of the articular cartilage in that joint, and also inhibited
the local uptake of S35, without affecting the cartilage in other areas (12).
Similarities between the Effects of Papain and Vitamin A on Cartilage
In 1952, Fell and Mellanby (13) described the effects of hypervitaminosis A on
embryonic bone explants in organ cultures. Witiin 4 or 5 days after growth in
media containing excess vitamin A, fetal chick and mouse bones exhibited a marked
degree of loss of metachromatic material from cartilage matrix, resulting in small,
deformed bones with greatdy impaired growth. When removed from excess vitamin
A, redeposition of metachromatic matrix occurred, and normal growth was resumed.
The histological resemblances between the effects of papain in the rabbit and
those of vitamin A on embryonic bones were noted by Fell and Thomas in 1958, and
a collaboratdve study of the relation between the events was undertaken. It was found
that the administration of vitamn A alcohol to rabbits resulted in collapse of their
ears within 2 or 3 days, and the cartilaginous tissues of these animals showed changes
indistinguishable from those following an injection of papain (14). Basophilia and
metachromasia disappeared from the matrix during the period of treatment, and
reappeared after discontinuation. The epiphyseal cartilage, as with papain, was the
most sensitive of all tissues to the lytic effect of vitamin A.
The two agents were found by Fell and Thomas (15) to exert similar effects in
embryonic bone cultures. The addition of crystalline papain protease to organ cul-
tures of mouse and chicken bone rudiments caused the rapid disappearance of
metachromatic material from cartilage matrix, and impa ent of growth. It was of
special interest that oxidized papain was as effective in cultures as reduced papain,
suggesting, as in the rabbit experiments, some mechanism in cartilage matrix for
activadon of the enzyme. No other elements of the bone rudiments were damaged by
papain, nor did lysis of the plasma clots occur.
In the light of these experiments, it was suggested, as a working hypothesis, that
"the changes in cartilage seen in experimental hypervitaminosis A may be the result
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of activation of a proteolytic enzyme or enzymes with properties similar to papain"
(15).
Lucy, Dingle, and Fell (16) demonstrated the presence of a proteolytic enzyme
in embryonic cartilage by incubating samples in hypotonic buffer; at pH 3-5 there
was rapid loss of metachromatic material from the matrix. Aqueous extracts of the
tissue contained an active protease with a pH optimum against hemoglobin of about
3.0. When cartilage was homogenized in isotonic sucrose, there was little or no
release of enzyme, but fractional centrifugation of the sucrose homogenates, followed
by hypotonic treatment of the fractions, revealed that about 85 per cent of the
enzyme was contained in an inactive, particulate form. Hypotonicity and acidifica-
tion brought about full activity in the sediments of sucrose homogenates. Thus, it
appeared that the cathepsins of cartilage might be contained in lysosomes, as de
Duve (17) had previously demonstrated in various tissues, and Dingle (18) under-
took a study of the action of vitamin A on lysosomes. Rat liver was chosen as the
most convenient source, employing the methods of de Duve for isolation of the
lysosome-rich fraction in 0.25 M sucrose. It was found by Dingle that the addition
of vitamin A alcohol to suspensions of lysosomes caused the release of soluble
cathepsin; this reaction was temperature- and pH-dependent and exhibited a high
degree of molecular specificity for vitamin A. The enzyme liberated from rat liver
lysosomes produced rapid degradation of embryonic cartilage matrix in vitro, with
liberation of chondroitin sulfate and loss of metachromasia (19).
Another model for the study of the action of vitamin A was introduced by Weiss-
mann, based on the finding of Weber (20) that in the metamorphosing toad tadpole
(Xenopus laevis), lysosomal enzymes become concentrated in the tail at the time
when tail resorption occurs. Weber suggested that enzyme release might be the
mechanism underlying resorption of this tissue. Weissmann postulated that in this
case the feeding of excess vitamin A should lead to premature resorption of the tad-
pole tail before metamorphosis, and found that this was indeed the case (21). In
addition, he observed a striking depletion of metachromatic material from the ground
substance in other tissues, including the rostral tentacles, which collapsed after the
administration of vitamin A in a manner reminiscent of the reaction in rabbits.
Prevention by Cortisone of the Effects of Vitamin A on Lysosomes
In view of the previously demonstrated inhibition by cortisone of the reconstitution
of cartilage matrix following papain ( 1, 12), it was thought that the effects of vitamin
A might be exaggerated or prolonged by steroid treatment. However, the contrary
proved to be true. Treatment of rabbits with cortisone before the administration of
vitamin A blocked completely the lytic effect on cartilage matrix (22). Injection of
prednisolone into one knee joint resulted in selective protection of the articular
cartilage of that joint, indicating that the action of cortisone was a direct one on
cartilage itself. Similar findings were obtained in organ cultures of embryonic bone
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by Fell and Thomas (23). The addition of hydrocortisone to the medium conveyed
almost complete protection against excess vitamin A.
These observations suggested that cortisone might have the property of stabilizing
lysosomes, in vivo, against the lytic action of vitamin A. Weissman and Dingle (24)
provided evidence for the same property in vitro. They learned that exposure of rat
liver lysosomes to ultraviolet light caused the release of cathepsin and other lysosomal
enzymes; pretreatment of the rats with cortisone before preparing the lysosome
suspensions caused a significant decrease in fragility to ultraviolet light. Similarly,
Weissmann and Thomas (25) have found that hydrocortisone added to lysosomes
in vitro wiUl block the lytic action of vitamin A.
In the experimental model involving hypervitaminosis A in the toad tadpole, ex-
periments with hydrocortisone at first yielded results which were quite contrary to
those above. When tadpoles were fed excess vitamin in the form of vitamin A
alcohol, and simultaneously given hydrocortisone, the effect was magnified and
accelerated. These results seemed more in accord with those obtained by Selye (26)
in rats; this author found that the skeletal fractures caused by prolonged treatment
with vitamin A were made worse by steroids. However, it now seems possible that
the paradoxical findings may be based on the fact that cortisone has two separate
properties-to stabilize lysosomes and prevent cartilage breakdown (as in the
vitamin A experiments) and to interfere with the reconstitution of matrix (as in the
papain experiments). In a long term experiment with chronic hypervitaminosis A,
it is conceivable that the effectiveness of cortisone in preventing lysis might become
outweighed by its capacity to prevent repair, and the end result might thus resemble
synergism between the two agents. The protective effect of cortisone is most readily
demonstrated in an acute experiment, as has recently been shown with tadpoles fed
vitamin A acid. The latter form of the vitamin is much more rapidly effective than
the alcohol in the tadpole, and is not stored in the liver. Hydrocortisone provides
complete protection of tadpoles against the action of vitamin A acid (27).
REFERENCES
1. THOMAS, L., J. Exp. Med., 1956, 104, 245.
2. KELLNER, A., and ROBERTSON, T., J. Exp. Med., 1954, 99, 387.
3. WESTERBORN, O., Acta Chir. Scantd., 1961, suppl. 270.
4. BRYANT, J. H., LEDER, I. G., and STETTEN, D., Arch. Biochem. and Biophysics, 1958, 76,
122.
5. TSALTAS, T. T., J. Exp. Med., 1958, 108, 307.
6. POTTER, J. L., MCCLUSKEY, R. T., WEISSMANN, G., and THOMAS, L., J. Exp. Med., 1960,
112, 1173.
7. KIMMEL, J. R., and SMITH, E. L., Adv. Enzymol., 1957, 14, 267
8. MCCLUSKEY, R. T., and THOMAS, L., J. Exp. Med., 1958, 108, 371.
9. LAYTON, L. L., Arch. Biochem., 1951, 32, 224.
10. BOSTROM, H., and ODEBLAD, E., Ark. Kemi, Mineral. och Geol., 1953, 6, 39.
11. SCHILLER, S., and DORFMAN, A., Endocrinology, 1957, 60, 376.
12. MCCLUSKEY, R. T., and THOMAS, L., Am. J. Path., 1959, 35, 819.
212 BIOLOGICAL ASPECTS OF MUCOPOLYSACCHARIDE METABOLISM
13. FELL, H. B., and MELLANBY, E., J. Physiol., 1952, 116, 320.
14. THOMAS, L., MCCLUSKEY, R. T., POTTER, J. L., and WEISSMANN, G., J. Exp. Med., 1960,
111, 705.
15. FELL, H. B., and THOMAS, L., J. Exp. Med., 1960, 111, 719.
16. Lucy, J. A., DINGLE, J. T., and FELL, H. B., Biochem. J., 1961, 79, 500.
17. DE DUVE, C., in Subcellular Particles, (T. Hayashi, editor), New York, Ronald Press Co.,
1959, 128.
18. DINGLE, J. T., Biochem. J., 1961, 79, 509.
19. DINGLE, J. T., Proc. Roy. Soc. Med., 1962, 55, 109.
20. WEBER, R., Experientia, 1957, 13, 153.
21. WEISSMANN, G., J. Exp. Med., 1961, 114, 581.
22. THOMAS, L., MCCLUSKEY, R. T., Li, J., and WEISSMANN, G., Am. J. Path., 1963, 42, 271.
23. FELL, H. B., and THOMAS, L., J. Exp. Med., 1961, 114, 343.
24. WEISSMANN, G., and DINGLE, J. T., Exp. Cell Research, 1961, 25, 207.
25. WEISSMANN, G., and THOMAS, L., J. Clin. Inv., 1963, 42, 661.
26. SELYE, H., Arthritis and Rheunmatism, 1958, 1, 87.
27. WEISSMANN, G., BELL, E., and THOMAS, L., Am. J. Path., 1963, 42, 571.
LEWIS THOMAS Cartilage Matrix in Vivo 213
